Biocryst Pharmaceuticals buy Wedbush
Start price
25.02.25
/
50%
€7.80
Target price
25.02.26
€14.28
Performance (%)
-15.99%
Price
29.12.25
€6.56
Summary
This prediction is currently active. The price of Biocryst Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.99%. This prediction currently runs until 25.02.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | 1.329% | 1.329% |
| iShares Core DAX® | 0.323% | 2.208% |
| iShares Nasdaq 100 | 0.145% | -0.987% |
| iShares Nikkei 225® | 0.091% | -1.421% |
| iShares S&P 500 | 0.371% | -0.469% |
Comments by Wedbush for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is now covered by analysts at Wedbush. They set an "outperform" rating and a $15.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Wedbush for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€15.36
30.06.26
30.06.26
-13.76%
29.12.25
29.12.25
